Analysts See $0.24 EPS for Newmont Mining (NEM), Gemphire Therapeutics (GEMP) Shorts Increased By 12.14%

July 12, 2017 - By Vivian Park

Analysts expect Newmont Mining Corp (NYSE:NEM) to report $0.24 EPS on July, 19.They anticipate $0.20 EPS change or 45.45% from last quarter’s $0.44 EPS. NEM’s profit would be $129.94M giving it 34.32 P/E if the $0.24 EPS is correct. After having $0.25 EPS previously, Newmont Mining Corp’s analysts see -4.00% EPS growth. The stock increased 1.32% or $0.43 during the last trading session, reaching $32.95. About 1,260 shares traded. Newmont Mining Corp (NYSE:NEM) has declined 1.49% since July 12, 2016 and is downtrending. It has underperformed by 18.19% the S&P500.

Gemphire Therapeutics Incorporated (NASDAQ:GEMP) had an increase of 12.14% in short interest. GEMP’s SI was 227,200 shares in July as released by FINRA. Its up 12.14% from 202,600 shares previously. With 30,500 avg volume, 7 days are for Gemphire Therapeutics Incorporated (NASDAQ:GEMP)’s short sellers to cover GEMP’s short positions. The SI to Gemphire Therapeutics Incorporated’s float is 6.29%. The stock increased 2.65% or $0.34 on July 11, reaching $13.19. About shares traded. Gemphire Therapeutics Inc (NASDAQ:GEMP) has 0.00% since July 12, 2016 and is . It has underperformed by 16.70% the S&P500.

Gemphire Therapeutics Inc. is a clinical-stage biopharmaceutical company. The company has market cap of $137.67 million. The Firm is engaged in the development and commercialization of therapeutics to treat cardiovascular and metabolic diseases. It currently has negative earnings. It is developing its product candidate, gemcabene , which is a once-daily, oral therapy for patients who are unable to achieve normal levels of low-density lipoprotein cholesterol (LDL-C) or triglycerides with approved therapies, primarily statin therapy.

Among 3 analysts covering Gemphire Therapeutics (NASDAQ:GEMP), 3 have Buy rating, 0 Sell and 0 Hold. Therefore 100% are positive. Gemphire Therapeutics had 3 analyst reports since August 30, 2016 according to SRatingsIntel. The rating was initiated by Jefferies with “Buy” on Tuesday, August 30. The rating was initiated by Canaccord Genuity on Tuesday, August 30 with “Buy”. The stock of Gemphire Therapeutics Inc (NASDAQ:GEMP) earned “Outperform” rating by RBC Capital Markets on Tuesday, August 30.

Since January 31, 2017, it had 0 buys, and 10 insider sales for $1.07 million activity. Another trade for 5,700 shares valued at $199,500 was made by Engel E Randall on Tuesday, June 6. $53,745 worth of Newmont Mining Corp (NYSE:NEM) shares were sold by Lawson Scott P. Goldberg Gary J sold $33,740 worth of stock or 1,000 shares. Another trade for 2,006 shares valued at $70,210 was made by MacGowan William N on Tuesday, June 6.

Among 23 analysts covering Newmont Mining Corporation (NYSE:NEM), 12 have Buy rating, 0 Sell and 11 Hold. Therefore 52% are positive. Newmont Mining Corporation had 66 analyst reports since July 24, 2015 according to SRatingsIntel. As per Thursday, January 7, the company rating was downgraded by RBC Capital Markets. HSBC downgraded the stock to “Hold” rating in Monday, October 26 report. The firm has “Hold” rating by Jefferies given on Tuesday, June 20. The stock of Newmont Mining Corp (NYSE:NEM) earned “Mkt Perform” rating by FBR Capital on Thursday, November 10. Jefferies upgraded the stock to “Buy” rating in Tuesday, January 12 report. The firm has “Hold” rating by RBC Capital Markets given on Monday, June 12. The firm earned “Hold” rating on Tuesday, September 22 by Zacks. The stock has “Neutral” rating by Clarkson Platou on Monday, April 18. The stock of Newmont Mining Corp (NYSE:NEM) earned “Buy” rating by Credit Suisse on Friday, April 28. The firm has “Buy” rating given on Monday, April 24 by BMO Capital Markets.

Investors sentiment decreased to 0.85 in 2016 Q4. Its down 0.01, from 0.86 in 2016Q3. It dived, as 108 investors sold Newmont Mining Corp shares while 164 reduced holdings. 60 funds opened positions while 171 raised stakes. 367.62 million shares or 0.42% more from 366.10 million shares in 2016Q3 were reported. 41,989 are owned by Sumitomo Life. Van Eck Assocs accumulated 34.51 million shares. New York-based Hap Trading Ltd Liability Com has invested 0.03% in Newmont Mining Corp (NYSE:NEM). 72,604 were reported by Mason Street Advsrs Ltd Llc. Cipher Capital Lp holds 0.05% or 20,934 shares in its portfolio. Amica Retiree Med owns 3,025 shares. Jump Trading Lc invested 0% of its portfolio in Newmont Mining Corp (NYSE:NEM). Kornitzer Ks stated it has 0.08% of its portfolio in Newmont Mining Corp (NYSE:NEM). Blackrock Inv Management Limited Liability holds 0.05% or 1.30 million shares in its portfolio. Ontario Teachers Pension Plan Board owns 46,561 shares. Fjarde Ap has invested 0.09% of its portfolio in Newmont Mining Corp (NYSE:NEM). Hanson Mcclain Inc has 0% invested in Newmont Mining Corp (NYSE:NEM) for 12 shares. Cap Fund Mngmt has invested 0.12% in Newmont Mining Corp (NYSE:NEM). Voloridge Invest Management Limited has 113,463 shares for 0.08% of their portfolio. Martingale Asset Lp stated it has 396,171 shares.